Skip to content
Open access · CC-BY via OpenAlex

MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism

Yen My Vuu, Chris-Tiann Roberts, Mojgan Rastegar

International Journal of Molecular Sciences · 2023 · ▲ 51 citations

Abstract

DNA methylation, one of the most well-studied epigenetic modifications, is involved in a wide spectrum of biological processes. Epigenetic mechanisms control cellular morphology and function. Such regulatory mechanisms involve histone modifications, chromatin remodeling, DNA methylation, non-coding regulatory RNA molecules, and RNA modifications. One of the most well-studied epigenetic modifications is DNA methylation that plays key roles in development, health, and disease. Our brain is probably the most complex part of our body, with a high level of DNA methylation. A key protein that binds to different types of methylated DNA in the brain is the methyl-CpG binding protein 2 (MeCP2). MeCP2 acts in a dose-dependent manner and its abnormally high or low expression level, deregulation, and/or genetic mutations lead to neurodevelopmental disorders and aberrant brain function. Recently, some of MeCP2-associated neurodevelopmental disorders have emerged as neurometabolic disorders, suggesting a role for MeCP2 in brain metabolism. Of note, MECP2 loss-of-function mutation in Rett Syndrome is reported to cause impairment of glucose and cholesterol metabolism in human patients and/or mouse models of disease. The purpose of this review is to outline the metabolic abnormalities in MeCP2-associated neurodevelopmental disorders that currently have no available cure. We aim to provide an updated overview into the role of metabolic defects associated with MeCP2-mediated cellular function for consideration of future therapeutic strategies.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ijms24044218
Canonical
link ↗
Fetched
2026-10-04 MST

Cite this

APA
Vuu, Y.M., Roberts, C., &amp; Rastegar, M. (2023). MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms24044218
Vancouver
Vuu YM, Roberts C, Rastegar M. MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044218.
BibTeX
@article{yen2023MeCPIs, title = {MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism}, author = {Yen My Vuu and Chris-Tiann Roberts and Mojgan Rastegar}, journal = {International Journal of Molecular Sciences}, year = {2023}, doi = {10.3390/ijms24044218}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings